Drug Profile
MF 101
Alternative Names: Menerba; Menopause Formula 101; MF-101Latest Information Update: 27 May 2015
Price :
$50
*
At a glance
- Originator Bionovo
- Class Flavanones
- Mechanism of Action Selective estrogen receptor beta agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Suspended Vasomotor symptoms
Most Recent Events
- 03 Apr 2012 Bionovo voluntarily suspends further enrolment in the phase III HERBA trial for Menopausal vasomotor symptoms in USA
- 26 Oct 2011 Phase-III clinical trials in Menopausal vasomotor symptoms in USA (PO)
- 30 Aug 2011 Adverse events data from a phase I trial in Vasomotor symptoms released by Bionovo